Georgia Cancer Specialists Welcomes Dr. Gerald Goldklang

Tuesday, May 19th, 2009

Georgia Cancer Treatment Center’s Fayetteville, Stockbridge Offices Merge with GCS; Dr. Goldklang Also Brings His Atlanta Medical Center Office to GCS

Gerald Goldklang, MDGeorgia Cancer Specialists (GCS) — the largest private medical oncology/hematology practice in the Southeast — continues to grow and expand its services with the addition of Dr. Gerald Goldklang to its Fayetteville and Stockbridge offices, as well as the addition of Dr. Goldklang’s Atlanta Medical Center office. GCS now has 42 physicians and 30 offices.

Dr. Goldklang merged the Fayetteville and Stockbridge offices of his practice – Georgia Cancer Treatment Center – with GCS’s offices in those areas. He also brought his Atlanta Medical Center office, which is separate from the Georgia Cancer Treatment Center, to GCS. Dr. Goldklang is currently seeing patients at all three offices.

Dr. Goldklang will also be practicing at GCS’s Newnan office, to open in June.

“Dr. Goldklang comes to us with a wealth of experience in the Atlanta market, and the addition of his Atlanta Medical Center office allows us to expand our care to an area we were previously absent from,” said Dr. Bruce Feinberg, President/CEO of GCS.

Dr. Goldklang’s staff also joins GCS through the merger. Now working with GCS are: RNs Diane Fleming and Valerie Cato; PSRs Christine Artkhaxa and Lesa Thammasack; MAs Julia Hernandez and Tiffany Worley; and Lab worker Juli Yoder.

Dr. Goldklang completed his fellowship at Tufts University – Baystate Medical Center in Springfield, MA, and his residency at Tufts University – St. Elizabeth Hospital in Brighton, MA. He received his medical degree from Tufts University School of Medicine in Boston, MA. His areas of special interest are patient care, clinical trials, and oncology research.

Dr. Goldklang is a member of the American Medical Association, the Medical Association of Georgia, the Medical Association of Atlanta, the American College of Physicians, the American Society of Clinical Oncology, and the Georgia Society of Clinical Oncology. He has published and presented several reports, including High-Dose Ara C and Cisplatin in Metastatic Non-small Cell Lung Carcinoma, Phase II Trial of High Dose Cytarabine and 1989 Cisplatin in previously Untreated Non-small Cell Carcinoma of the Lung, and Association between Primary Thrombocytosis 1995 and Multiple Myeloma.

Dr. Goldklang currently practices at these GCS locations:

GCS-Atlanta Medical Center




© 2024, GEORGIA CANCER SPECIALISTS Administrative Annex . All Rights Reserved.